Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Ratings and Price Targets for Carvana March 2024

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Automotive Trading online
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

As of March 12, 2024, analysts have varying opinions on Carvana (NYSE: CVNA), ranging from bullish to bearish. Here is a breakdown of the recent analyst ratings:

– Total Ratings: 0 Bullish, 2 Somewhat Bullish, 4 Indifferent, 2 Somewhat Bearish, 0 Bearish.
– Recent Changes in Ratings (Last 30 Days): 1 Indifferent.
– Analysts’ Evaluations of 12-Month Price Targets: Average target of $64.38, high estimate of $90.00, low estimate of $45.00. The current average has increased by 60.39% from the previous average price target of $40.14.

Recent analyst actions include:
– John Colantuoni from Jefferies upgraded the rating to Hold with a price target of $85.00.
– Brad Erickson from RBC Capital upgraded the rating to Sector Perform with a price target of $90.00.
– Adam Jonas from Morgan Stanley downgraded the rating to Underweight with a price target of $45.00.
– Nicholas Jones from JMP Securities upgraded the rating to Market Outperform with a price target of $80.00.
– Seth Basham from Wedbush upgraded the rating to Neutral with price targets ranging from $50.00 to $60.00.

Overall, Carvana currently has a consensus rating of Hold based on 2 buy ratings, 11 hold ratings, and 2 sell ratings, with an average price target of $60.91.

Carvana Co. (CVNA) Stock Price Plummets 8.43% Amidst Market Turbulence

Carvana Co. (CVNA) had a tumultuous day on March 12, 2024, with the stock experiencing significant price movements. According to data from CNN Money, CVNA was trading near the top of its 52-week range and above its 200-day simple moving average, indicating positive price momentum leading up to the trading day.

However, things took a turn for the worse as CVNA shares dropped $7.19, or 8.43%, since the market last closed. The stock closed at $78.10, marking a significant decrease from the previous trading session. Investors may have been concerned about the sudden drop in price, leading to a sell-off of CVNA shares.

Despite the decline, there was some positive news for CVNA investors as the stock rose $2.17 in pre-market trading. This increase could indicate that investors are optimistic about the stock’s future performance and may be looking to buy shares at a discounted price.

Carvana Co. (CVNA) Financial Results and Stock Performance Analysis – March 12, 2024

On March 12, 2024, Carvana Co. (CVNA) experienced a mixed day in terms of stock performance, reflecting the company’s recent financial results. According to data from CNN Money, CVNA reported total revenue of $10.77 billion over the past year, with a significant decrease of 20.82% compared to the previous year. In the fourth quarter alone, total revenue stood at $2.42 billion, showing a 12.59% decrease from the previous quarter.

Despite the decline in revenue, CVNA managed to increase its net income by 128.36% from the previous year, reaching $450 million in the past year. However, in the fourth quarter, the company reported a net loss of $114 million, marking a decrease of 114.58% from the previous quarter.

Earnings per share (EPS) for CVNA also showed a mixed performance. The company reported an EPS of $0.75 over the past year, reflecting a 104.75% increase from the previous year. In the fourth quarter, however, EPS dropped to -$1.00, remaining unchanged from the previous quarter.

The fluctuating financial results of CVNA seem to have had an impact on its stock performance on March 12, 2024. Investors may have reacted to the mixed results, leading to fluctuations in the stock price throughout the trading day.

Tags: CVNA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Automotive Trading online

Revolutionizing the EV Industry Ferroglobe and Coreshells Breakthrough in BatteryGrade Metallurgical Silicon

Enhancing DeepView SnapShot M Spectral AI Inc Secures Government Contract for Wound Imaging System Development

Sotagliflozin Shows Promise in Improving Glycemic Control for Patients with Type 1 Diabetes and Chronic Kidney Disease

Recommended

FCBC stock news

Impax Asset Management Group plc Reduces Stake in Snap Inc. as Insiders Sell Off Shares

2 years ago
The Trade Desk Stock

The Trade Desk: A Market Conundrum of Conflicting Signals

3 months ago
Intel Stock

US Government Holds Massive Intel Share Position, Creating Market Uncertainty

5 months ago
Nuvalent Stock

Nuvalent Shares Surge on Promising Clinical Trial Results

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

DroneShield Shares Face Headwinds Despite Record Performance

Rock Tech Lithium: Investors Await the Final Go-Ahead

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Trending

KemPharm Stock
Analysis

Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion

by Kennethcix
February 8, 2026
0

Zevra Therapeutics continues to build its profile as a dedicated rare disease company. Recent clinical data presentations...

Oak Valley Stock

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

February 8, 2026
SuRo Capital Stock

SuRo Capital Sharpens Focus on AI Infrastructure Investments

February 8, 2026
Chicago Atlantic Real Estate Finance Stock

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

February 8, 2026
RBB Stock

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion
  • Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit
  • SuRo Capital Sharpens Focus on AI Infrastructure Investments

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com